Re: Crazy Question
in response to
by
posted on
Jan 05, 2024 03:06PM
Fuzzyjr wrote;
"As far eversana goes - is it confidential as they prepare to take rvx to court over the overwhelming debt? Last we heard eversana was sitting on the bench/sidelined, right? If not rvx might have been or still racking up an even larger debt to them?"
So mark your calendars : May 13, 2024
From RVX website:
CALGARY, Alberta, March 20, 2023 - Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0 million secured convertible debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink"), and payment of accrued interest thereon, extending the maturity date to May 13, 2024. In connection with the extension, the interest rate was amended from 10% to 12% per annum, commencing on May 14, 2023.
So who will be the first one to eat?
Long.